Biotech startups that raised a seed round in the United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Imperagen | Manchester | Seed | $6.7M | 2026-05-20 |
| Fermtech | Oxford | Seed | $3.3M | 2026-04-07 |
| Corryn Biotechnologies | Morriston | Seed | $662K | 2026-04-01 |
| sable bio | London | Seed | $3.8M | 2026-02-11 |
| Early Health | London | Seed | $4.7M | 2026-02-10 |
| Sparxell | Cambridge | Seed | $5.0M | 2026-02-03 |
| Infinitopes | Oxford | Seed | $15.4M | 2026-01-21 |
| Emm | London | Seed | $8.9M | 2025-11-19 |
8 rows of the CSV in 5 of its 18 columns.
- The 315 biotech startups in the United Kingdom whose last round is a seed round have raised $660.2M in total.
- 42 of them closed their most recent round in the last 12 months, $210.4M combined.
- The largest of those rounds is Syndex Bio's $15.5M seed round, dated February 2026.
- The most recent is OCTOPATH AI's $2.0M seed round on 2 November 2026.
- Innovate UK is an investor in 13 of them, more than any other fund.
- Health care is the most common other sector, with 216 companies (69%).
- 43% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (61% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 315| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Manchester | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
| Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Oxford | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
| Corryn Biotechnologies | Corryn Biotechnologies develops wound dressing devices for chronic and complex wounds. | Biotech | Morriston | Seed | $662K | 2026-04-01 | $1.6M | SFC Capital, Innovate UK | 1 to 10 | 2021 |
| sable bio | Sable Bio uses artificial intelligence to analyze large biomedical datasets and test drug candidates for toxicity. | Artificial intelligence | London | Seed | $3.8M | 2026-02-11 | $5.6M | Seedcamp, Episode 1 | 1 to 10 | 2023 |
| Early Health | Early Health makes consumer bathroom hardware that detects early signs of illness. | Biotech | London | Seed | $4.7M | 2026-02-10 | $4.7M | LocalGlobe, SoftBank Vision Fund, Atomico +1 | 1 to 10 | 2022 |
| Sparxell | Sparxell creates new colors and effects. | Biotech | Cambridge | Seed | $5.0M | 2026-02-03 | $10.2M | Katapult, Joyance Partners, Earth Venture Capital +1 | 11 to 50 | 2022 |
| Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Oxford | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| Emm | Emm develops bio-wearable devices intended to improve healthcare. | Biotech | London | Seed | $8.9M | 2025-11-19 | $9.9M | Alumni Ventures, Innovate UK, Sie Ventures | 11 to 50 | 2020 |
| InvenireX | InvenireX offers molecular diagnostics services as a biotechnology company. | Biotech | Newcastle Upon Tyne | Seed | $2.6M | 2025-11-18 | $3.3M | XTX Ventures, DSW Ventures | 1 to 10 | 2021 |
| Amped PCR | Amped PCR manufactures reagents and develops PurifAI. | Artificial intelligence | Cardiff | Seed | $679K | 2024-12-16 | SFC Capital | 1 to 10 | 2022 | |
| Shift Bioscience | Shift Bioscience discovers drug targets for age-linked diseases using simulation. | Artificial intelligence | Cambridge | Seed | $16.3M | 2024-10-15 | Healthspan Capital | 11 to 50 | 2017 | |
| CardiaTec Biosciences | CardiaTec Biosciences combines AI and expert talent to redesign cardiovascular drug discovery. | Artificial intelligence | Cambridge | Seed | $6.5M | 2024-09-10 | APEX Ventures, Montage Ventures, Continuum Health Ventures +1 | 11 to 50 | 2021 | |
| ScubaTx | ScubaTx commercialises persufflation, a method of preserving donor organs. | Biotech | Newcastle Upon Tyne | Seed | $1.8M | 2024-09-03 | $3.7M | Innovate UK, Praetura Ventures, GM&C Life Sciences Fund | 1 to 10 | 2020 |
| ŌGI Bio | ŌGI Bio conducts biotechnology research. | Biotech | Edinburgh | Seed | $826K | 2024-06-18 | Scottish Enterprise, Old College Capital, Apollo +2 | 1 to 10 | 2020 | |
| Xias Bio | Xias Bio produces soluble, active recombinant proteins for formulators to improve gel and film formation. | Biotech | Glasgow | Seed | $4.8M | 2024-05-01 | SOSV, SOSV SF & NY (Fka IndieBio) | 11 to 50 | 2020 | |
| Metallo Bio | Metallo Bio develops two lead chemicals representing a new class of antibiotics. | Biotech | Sheffield | Seed | $202K | 2024-04-04 | $573K | SFC Capital, Innovate UK | 1 to 10 | 2021 |
| Evolutor | Evolutor develops proprietary microbiology technology to advance evolution beyond current possibilities. | Biotech | Sheffield | Seed | $295K | 2024-04-03 | SFC Capital | 1 to 10 | 2022 | |
| Impulsonics | Impulsonics uses acoustic waves to advance biotech automation and cell and tissue engineering. | Biotech | Bristol | Seed | $568K | 2024-03-27 | SFC Capital, British Business Investments | 1 to 10 | 2023 | |
| Wobble Genomics | Wobble Genomics maximizes the efficiency of RNA and DNA sequencing to detect nucleic acid biomarkers. | Biotech | Edinburgh | Seed | $10.9M | 2024-03-07 | $12.9M | Scottish Enterprise, IQ Capital, Business Growth Fund +2 | 11 to 50 | 2021 |
| Zetta Genomics | Zetta Genomics manages large-scale genomic data for precision medicine. | Biotech | Cambridge | Seed | $2.3M | 2024-02-08 | $8.0M | Nina Capital, APEX Ventures, University of Cambridge Enterprise +1 | 11 to 50 | 2018 |
| PulmoBiomed | PulmoBiomed provides a non-invasive way for clinicians and researchers to sample fluids. | Biotech | Newcastle Upon Tyne | Seed | $883K | 2024-02-08 | $1.8M | SFC Capital, Innovate UK, Northeast Venture Fund ( NEVF ) | 1 to 10 | 2020 |
| Carcinotech | Carcinotech manufactures 3D printed living tumours for cancer research. | Biotech | Edinburgh | Seed | $5.3M | 2024-01-29 | $7.4M | Scottish Enterprise, Maven Capital Partners, Old College Capital +2 | 11 to 50 | 2018 |
| CellVoyant Technologies | CellVoyant Technologies develops AI-driven stem cell therapies and manufactures cells and tissues at scale. | Artificial intelligence | Bristol | Seed | $9.7M | 2024-01-15 | $9.7M | Octopus Ventures, Verve Ventures, Horizons Ventures +1 | 11 to 50 | 2021 |
| Cumulus Oncology | Cumulus Oncology develops anti-cancer therapies for areas of high unmet clinical need. | Biotech | Edinburgh | Seed | $11.5M | 2024-01-08 | $17.0M | Scottish Enterprise, Eos, Scottish National Investment Bank | 11 to 50 | 2017 |
| clear_pixel VR | clear_pixel VR delivers virtual reality training for laboratory and pharmaceutical skills. | Biotech | Cardiff | Angel | $459K | 2023-10-18 | Development Bank of Wales | 1 to 10 | 2020 | |
| MarraBio | MarraBio develops functional protein polymers that help cells divide, expand, and function. | Biotech | Newcastle Upon Tyne | Seed | $619K | 2023-09-18 | Northstar Ventures, Maven Capital Partners | 1 to 10 | 2022 | |
| DName-iT | DName-iT is a genetic analysis company offering DNA-based barcode labelling technology and a software platform. | Biotech | Belfast | Seed | $634K | 2023-06-30 | $634K | Gemma Frisius Fund, EMV Capital | 1 to 10 | 2014 |
| Saffe | Saffe provides AI face recognition and liveness detection with a privacy-first antifraud risk scoring solution. | Artificial intelligence | London | Seed | $950K | 2023-03-01 | Wayra, CFV Ventures, Queen City Fintech +1 | 1 to 10 | 2015 | |
| Re:course | Re:course is a platform where clinicians build practical skills by applying theory immediately. | Biotech | Manchester | Seed | $4.3M | 2023-02-02 | Praetura Ventures, Par Equity, Northern Gritstone | 11 to 50 | 2018 | |
| Cambridge Phenotyping | Cambridge Phenotyping uses AI technology to help scientists analyze animal behavior. | Artificial intelligence | London | Seed | $658K | 2022-04-19 | 70Ventures, Coinvest Capital | 1 to 10 | 2020 |
Table 1. Biotech startups that raised a seed round in the United Kingdom: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 315.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Oxford | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| 2 | Emm | Emm develops bio-wearable devices intended to improve healthcare. | Biotech | London | Seed | $8.9M | 2025-11-19 | $9.9M | Alumni Ventures, Innovate UK, Sie Ventures | 11 to 50 | 2020 |
| 3 | Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Manchester | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
| 4 | Sparxell | Sparxell creates new colors and effects. | Biotech | Cambridge | Seed | $5.0M | 2026-02-03 | $10.2M | Katapult, Joyance Partners, Earth Venture Capital +1 | 11 to 50 | 2022 |
| 5 | Early Health | Early Health makes consumer bathroom hardware that detects early signs of illness. | Biotech | London | Seed | $4.7M | 2026-02-10 | $4.7M | LocalGlobe, SoftBank Vision Fund, Atomico +1 | 1 to 10 | 2022 |
| 6 | sable bio | Sable Bio uses artificial intelligence to analyze large biomedical datasets and test drug candidates for toxicity. | Artificial intelligence | London | Seed | $3.8M | 2026-02-11 | $5.6M | Seedcamp, Episode 1 | 1 to 10 | 2023 |
| 7 | Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Oxford | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
| 8 | InvenireX | InvenireX offers molecular diagnostics services as a biotechnology company. | Biotech | Newcastle Upon Tyne | Seed | $2.6M | 2025-11-18 | $3.3M | XTX Ventures, DSW Ventures | 1 to 10 | 2021 |
| 9 | Corryn Biotechnologies | Corryn Biotechnologies develops wound dressing devices for chronic and complex wounds. | Biotech | Morriston | Seed | $662K | 2026-04-01 | $1.6M | SFC Capital, Innovate UK | 1 to 10 | 2021 |
Table 2. Biotech startups that raised a seed round in the United Kingdom: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 13 | 4% | 2 | Corryn Biotechnologies, Emm |
| 2 | SFC Capital | Angel group | Northwich, United Kingdom | 8 | 3% | 1 | Corryn Biotechnologies |
| 3 | Octopus Ventures | Venture capital firm | London, United Kingdom | 6 | 2% | 1 | Infinitopes |
| 4 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | 5 | 2% | ||
| 5 | APEX Ventures | Venture capital firm | Vienna, Austria | 4 | 1% | ||
| 6 | Eos | Venture capital firm | Saint Andrews, United Kingdom | 4 | 1% | ||
| 7 | TRICAPITAL | Startup accelerator | Melrose, United Kingdom | 3 | 1% | ||
| 8 | Old College Capital | University program | Edinburgh, United Kingdom | 3 | 1% | ||
| 9 | SOSV | Venture capital firm | Princeton, United States | 3 | 1% | ||
| 10 | MassChallenge | Startup accelerator | Boston, United States | 3 | 1% | ||
| 11 | Longevitytech.fund | Venture capital firm | Boca Raton, United States | 3 | 1% | ||
| 12 | UK Innovation & Science Seed Fund | Venture capital firm | Harwell, United Kingdom | 3 | 1% | ||
| 13 | Future Planet Capital | Venture capital firm | London, United Kingdom | 3 | 1% | ||
| 14 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | 3 | 1% | ||
| 15 | IQ Capital | Venture capital firm | London, United Kingdom | 2 | 1% | 1 | Imperagen |
Table 3. Biotech startups that raised a seed round in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 216 | 69% | $491.2M |
| Software | 75 | 24% | $134.0M |
| Artificial intelligence | 50 | 16% | $105.9M |
| Hardware | 12 | 4% | $33.6M |
| Fintech | 8 | 3% | $7.9M |
| Cybersecurity | 5 | 2% | |
| Education | 4 | 1% | |
| Energy | 2 | 1% |
Table 4. Biotech startups that raised a seed round in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 315 | 100% | $2.1M |
Table 5. Biotech startups that raised a seed round in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups that raised a seed round in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 5% | $2.0M |
| October 2026 | 3 | 7% | $7.0M |
| September 2026 | 4 | 10% | $11.1M |
| August 2026 | 2 | 5% | $2.3M |
| July 2026 | 2 | 5% | $29.7M |
| June 2026 | 2 | 5% | $136K |
| May 2026 | 6 | 14% | $33.6M |
| April 2026 | 4 | 10% | $21.2M |
| March 2026 | 4 | 10% | $13.7M |
| February 2026 | 5 | 12% | $31.1M |
| January 2026 | 2 | 5% | $24.9M |
| December 2025 | 2 | 5% | $3.5M |
| November 2025 | 4 | 10% | $30.1M |
Table 7. Biotech startups that raised a seed round in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 36 | 11% | $176.8M |
| 2025 | 33 | 10% | $103.0M |
| 2024 | 45 | 14% | $180.0M |
| 2023 | 38 | 12% | $126.7M |
| 2022 | 30 | 10% | $58.9M |
| 2021 | 25 | 8% | $47.2M |
Table 8. Biotech startups that raised a seed round in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 31 | 10% |
| 2020 to 2022 | 105 | 33% |
| 2015 to 2019 | 118 | 38% |
| 2010 to 2014 | 41 | 13% |
| Before 2010 | 19 | 6% |
Table 9. Biotech startups that raised a seed round in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 188 | 61% |
| 11 to 50 | 116 | 37% |
| 51 to 100 | 3 | 1% |
| 101 to 250 | 2 | 1% |
| 251 to 500 | 1 | 0% |
Table 10. Biotech startups that raised a seed round in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in the United Kingdom. On 16 November 2026 that is 315 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 315 rows: 103 have no round amount, 1 no city and 135 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in the United Kingdom whose last round is a seed round are on the list?
- 315, in the file dated 16 November 2026. 42 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 315 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.